e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
New molecular and cell biology mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: New entity of an isolated pulmonary Non-Langerhans cell histiocytosis
M. Kreuter, C. P. Heussel, C. Nagel, R. P. Baum, P. A. Schnabel, F. J. Herth, D. Theegarten (Heidelberg, Bad Berka, Essen, Germany)
Source:
Annual Congress 2013 –New molecular and cell biology mechanisms
Session:
New molecular and cell biology mechanisms
Session type:
Oral Presentation
Number:
5005
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kreuter, C. P. Heussel, C. Nagel, R. P. Baum, P. A. Schnabel, F. J. Herth, D. Theegarten (Heidelberg, Bad Berka, Essen, Germany). LATE-BREAKING ABSTRACT: New entity of an isolated pulmonary Non-Langerhans cell histiocytosis. Eur Respir J 2013; 42: Suppl. 57, 5005
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Erdheim-Chester disease: Patterns and pulmonary involvement
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011
Hughes-Stovin syndrome: A case report
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Analysis of multicentric Castleman’s disease (MCD) with pulmonary lesions
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Diffuse pulmonary ossification
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Cystic interstitial lung disease - a rare disease?
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in patients with pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011
Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Pirfenidone in diffuse parenchymal lung disease after stem cell transplantation of a patient with dyskeratosis congenita
Source: International Congress 2014 – ILDs 6
Year: 2014
Multiple cystic lung diseases
Source: Eur Respir Mon 2011; 54: 46-83
Year: 2011
Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept